Kapil Dhingra

Insider Reports History

Entity
Individual
Location
39 Bliss Avenue, Tenafly, NJ
Signature
/s/ Amy Garabedian, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kapil Dhingra:

Insider Reports Filed by Kapil Dhingra

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LVTX LAVA Therapeutics NV Feb 13, 2025 1 $0 4 Feb 18, 2025 Director
LVTX LAVA Therapeutics NV Jan 1, 2025 0 $0 3 Jan 2, 2025 Director
BDTX Black Diamond Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 6, 2024 Director
CRGX CARGO Therapeutics, Inc. Jun 4, 2024 1 $0 4 Jun 6, 2024 Director
CRGX CARGO Therapeutics, Inc. Apr 15, 2024 1 $0 4 Apr 17, 2024 Director
CRGX CARGO Therapeutics, Inc. Apr 15, 2024 0 $0 3 Apr 17, 2024 Director
REPL Replimune Group, Inc. Apr 1, 2024 1 $0 4 Apr 3, 2024 Director
BDTX Black Diamond Therapeutics, Inc. May 16, 2023 1 $0 4 May 17, 2023 Director
REPL Replimune Group, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director
BDTX Black Diamond Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
REPL Replimune Group, Inc. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director
BDTX Black Diamond Therapeutics, Inc. Jun 18, 2021 1 $0 4 Jun 22, 2021 Director